1.Comparison of safety and ef fi cacy between Nirmatrelvir-ritonavir and molnupiravir in the treatment of COVID-19 infection in patients with advanced kidney disease: a retrospective observational study

Chu, WM, Wan, EYF, W     More...

Chu, WM, Wan, EYF, Wong, ZCT, Tam, AR, Wong, ICK, Chan, EWY, Hung, IFN     Less

ECLINICALMEDICINE[2589-5370], Published 2024, Volume 72,

收錄情况： WOS SCOPUS

WOS核心合集引用: 0  2023影響因子:  9.6 

2.Effectiveness of molnupiravir vs nirmatrelvir-ritonavir in non- hospitalised and hospitalised patients with COVID-19: a target trial emulation study

Wan, EYF, Yan, VKC,     More...

Wan, EYF, Yan, VKC, Wong, ZCT, Chui, CSL, Lai, FTT, Li, X, Wong, CKH, Hung, IFN, Lau, CS, Wong, ICK, Chan, EWY     Less

ECLINICALMEDICINE[2589-5370], Published 2023, Volume 64,

收錄情况： WOS SCOPUS

WOS核心合集引用: 3  2023影響因子:  9.6  发表年影響因子:  9.6 

3.Risk of autoimmune diseases following COVID-19 and the potential protective effect from vaccination: a population based cohort study

Peng, K, Li, X, Yang     More...

Peng, K, Li, X, Yang, DL, Chan, SCW, Zhou, JY, Wan, EYF, Chui, CSL, Lai, FTT, Wong, CKH, Chan, EWY, Leung, WK, Lau, CS, Wong, ICK     Less

ECLINICALMEDICINE[2589-5370], Published 2023, Volume 63,

收錄情况： WOS SCOPUS

WOS核心合集引用: 38  2023影響因子:  9.6  发表年影響因子:  9.6 

4.Long-term post-acute sequelae of COVID-19 infection: a retrospective, multi-database cohort study in Hong Kong and the UK

Lam, ICH, Wong, CKH,     More...

Lam, ICH, Wong, CKH, Zhang, R, Chui, CSL, Lai, FTT, Li, X, Chan, EWY, Luo, H, Zhang, QP, Man, KKC, Cheung, BMY, Tang, SCW, Lau, CS, Wan, EYF, Wong, ICK     Less

ECLINICALMEDICINE[2589-5370], Published 2023, Volume 60,

收錄情况： WOS SCOPUS

WOS核心合集引用: 39  2023影響因子:  9.6  发表年影響因子:  9.6 

5.Attention-deficit/hyperactivity disorder medication consumption in 64 countries and regions from 2015 to 2019: a longitudinal study

Chan, AYL, Ma, TT, L     More...

Chan, AYL, Ma, TT, Lou, WCY, Lp, P, Coghill, D, Gao, L, Jani, YH, Hsia, YF, Wei, L, Taxis, K, Simonoff, E, Taylor, D, Lum, TY, Man, KKC, Wong, ICK     Less

ECLINICALMEDICINE[2589-5370], Published 2023, Volume 58,

收錄情况： WOS SCOPUS

WOS核心合集引用: 12  2023影響因子:  9.6  发表年影響因子:  9.6 

6.Development and validation of sex-specific hip fracture prediction models using electronic health records: a retrospective, population-based cohort study

Li, GHY, Cheung, CL,     More...

Li, GHY, Cheung, CL, Tan, KCB, Kung, AWC, Kwok, TCY, Lau, WCY, Wong, JSH, Hsu, WWQ, Fang, CS, Wong, ICK     Less

ECLINICALMEDICINE[2589-5370], Published 2023, Volume 58,

收錄情况： WOS SCOPUS

WOS核心合集引用: 11  2023影響因子:  9.6  发表年影響因子:  9.6 

7.Thromboembolic events and hemorrhagic stroke after mRNA (BNT162b2) and inactivated (CoronaVac) covid-19 vaccination: A self-controlled case series study

Chui, CSL, Fan, M, W     More...

Chui, CSL, Fan, M, Wan, EYF, Leung, MTY, Cheung, E, Yan, VKC, Gao, L, Ghebremichael-Weldeselassie, Y, Man, KKC, Lau, KK, Lam, ICH, Lai, FTT, Li, X, Wong, CKH, Chan, EW, Cheung, CL, Sing, CW, Lee, CK, Hung, IFN, Lau, CS, Chan, JYS, Lee, MKY, Mok, VCT, Siu, CW, Chan, LST, Cheung, T, Chan, FLF, Leung, AYH, Cowling, BJ, Leung, GM, Wong, ICK     Less

ECLINICALMEDICINE[2589-5370], Published 2022, Volume 50,

收錄情况： WOS SCOPUS

WOS核心合集引用: 34  2023影響因子:  9.6  发表年影響因子:  15.1 

8.Intramuscular midazolam, olanzapine, or haloperidol for the management of acute agitation: A multi-centre, double-blind, randomised clinical trial

Chan, EW, Lao, KSJ,     More...

Chan, EW, Lao, KSJ, Lam, L, Tsui, SH, Lui, CT, Wong, CP, Graham, CA, Cheng, CH, Chung, TS, Lam, HF, Ting, SM, Knott, JC, Taylor, DM, Kong, DCM, Leung, LP, Wong, ICK     Less

ECLINICALMEDICINE[2589-5370], Published 2021, Volume 32,

收錄情况： WOS SCOPUS

WOS核心合集引用: 12  2023影響因子:  9.6  发表年影響因子:  17.033